Progressive Web App About Individualized Patient Decision Aid for NSCLC Stage I-II

Study Overview
=================
Brief Summary
-----------------
Studies indicate that the majority of early-stage non-small cell lung cancer (NSCLC) patients find it important to be involved in treatment decision making. However, in a recent study it has been reported that about 40% of the participants experienced decision conflict and feel uninformed(1). The investigators therefore developed a patient decision aid (PDA) for stage I-II NSCLC patients, that informs and empowers patients to help decide between stereotactic radiotherapy (SBRT) and surgery.

Detailed Description
-----------------
A pilot study in which semi-structured interviews will be conducted (Qualitative research).In addition, patients will be asked to fill in a questionnaire about the usability of the prototype. A small group of patients (n=15) that have been treated for early stage NSCLC in the past will be asked to participate. The persons involved in this pilot are asked to assess a patient decision tool and will be interviewed only once. After the interview they will be asked to fill in a questionnaire. The burden of the pilot study is very low. No medical examinations or procedures will be carried out. Pilot study in lung cancer patients treated in the past with radiotherapy or surgery. The participants will all give informed consent. The investigators are using a qualitative design. Semi-structured interviews will be carried out. In addition the investigators will ask the participants to fill in a questionnaire with 35 questions. No age limits are defined. The pilot study will be carried out in stage I-II NSCLC patients who were treated with radiotherapy or surgery, at least 6 months ago. Patients should currently be free of disease, no disease progression. The semi-structured interview consists of 17 open questions and text recorded, in order to be able to analyze the date afterwards. The interviews will take place when the patients come to the hospital for a regular follow-up appointment. After the interview, the patient is asked to fill in a questionnaire about the usability of the decision aid. In total, the expected duration is about 2 hours.

Official Title
-----------------
Improving Decision Making by Developing and Testing a Progressive Web App About Patient Decision Aid for Stage I-II Non-small Cell Lung Cancer

Conditions
-----------------
Lung Cancer Stage I, Lung Cancer Stage II

Intervention / Treatment
-----------------
* Other: Patient Decision Aid


Participation Criteria
=================
Eligibility Criteria
-----------------
Inclusion Criteria: Early stage non-small cell lung patients, Treated with curative intent minimum 6 month ago, max 5 years. Doctors IT Exclusion Criteria: Others

Ages Eligible for Study
-----------------
Minimum Age: 21 Years
Maximum Age: 100 Years

Sexes Eligible for Study
-----------------
All

Accepts Healthy Volunteers
-----------------
Accepts Healthy Volunteers

Study Plan
=================
How is the study designed?
-----------------

Arms and Interventions

| Participant Group/Arm | Intervention/Treatment |
| --- | --- |
| IT specialist<br>20 IT Specialist will evaluate the usability and patient-friendliness of the tool | Other: Patient Decision Aid<br>* More than 20 IT specialists, 15 doctors and 15 patients<br>|
| Doctors<br>13 doctors will evaluate the information in the tool | Other: Patient Decision Aid<br>* More than 20 IT specialists, 15 doctors and 15 patients<br>|
| Patients<br>10-20 patients will evaluate the utility and the contribution of the tool in decision making proces. | Other: Patient Decision Aid<br>* More than 20 IT specialists, 15 doctors and 15 patients<br>|

What is the study measuring?
-----------------
Primary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |
| Usability of PDA | Opinion of the respondents about patient decision aid | 1 year | 
| The accuracy of the information in the tool | Testing the information provided in the tool and the usability of the tool itself | 1 year | 

 Terms related to the study
=================
Keywords Provided by Centre Hospitalier Valida
-----------------
iPDA, Shared decision making, Patient decision aids, Progressive web app